Anti‐LFA‐1 or rapamycin overcome costimulation blockade‐resistant rejection in sensitized bone marrow recipients. (13th December 2012)

• Record Type: Journal Article
• Authors: Ramsey, Haley; Pilat, Nina; Hock, Karin; Klaus, Christoph; Unger, Lukas; Schwarz, Christoph; Baranyi, Ulrike; Gattringer, Martina; Schwaiger, Elisabeth; Wrba, Fritz; Wekerle, Thomas
• Is Part Of: Transplant international. Volume 26:Number 2(2013:Feb.)
• Page Start: 206
• Page End: 218
• Publication Date: 2012-12-13
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; 617.95405
• DOI: 10.1111/tri.12021
• Languages: English
• ISSNs: 0934-0874

Abstract

<abstract abstract-type="main" id="tri12021-abs-0001"> <title>Summary</title> <p>While costimulation blockade‐based mixed chimerism protocols work well for inducing tolerance in rodents, translation to preclinical large animal/nonhuman primate models has been less successful. One recognized cause for these difficulties is the high frequency of alloreactive memory T cells (Tmem) found in the (pre)clinical setting as opposed to laboratory mice. In the present study, we therefore developed a murine bone marrow transplantation (BMT) model employing recipients harboring polyclonal donor‐reactive Tmem without concomitant humoral sensitization. This model was then used to identify strategies to overcome this additional immune barrier. We found that B6 recipients that were enriched with 3 × 10⁷ T cells isolated from B6 mice that had been previously grafted with Balb/c skin, rejected Balb/c BM despite costimulation blockade with anti‐CD40L and CTLA4Ig (while recipients not enriched developed chimerism). Adjunctive short‐term treatment of sensitized BMT recipients with rapamycin or anti‐LFA‐1 mAb was demonstrated to be effective in controlling Tmem in this model, leading to long‐term mixed chimerism and donor‐specific tolerance. Thus, rapamycin and anti‐LFA‐1 mAb are effective in overcoming the potent barrier that donor‐reactive Tmem pose to the induction of mixed chimerism and tolerance despite costimulation blockade.</p> </abstract>